Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprolide Acetate 11.25 mg and 30 mg in Children with CPP
NCT00635817Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2008
- Primary completion
- Jan 2010
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of leuprolide in central precocious puberty (CPP), sponsored by Abbott Laboratories. Started Jun 2008; status: completed.
02
Drugs
leuprolide
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on NCT00635817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635817.